Fulcrum therapeutics to participate at upcoming september investor conferences

Cambridge, mass., sept. 06, 2022 (globe newswire) -- fulcrum therapeutics, inc.  (nasdaq: fulc), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will participate in the following upcoming investor conferences:
FULC Ratings Summary
FULC Quant Ranking